Gerard Rotonda The acquisition "Accelerates the company’s vision for transforming healthcare and advancing patient care worldwide – from the hospital to the home. Combination creates opportunities for innovation that should drive efficiencies across care settings and help improve care outcomes. Complementary products and pipeline enable broader access to care globally. Expected to generate high single-digit ROIC by year five and approximately $250 million of annual pre-tax cost synergies by the end of year three. Positions Baxter for anticipated faster top- and bottom-line growth"
Gerard Rotonda

If they can get their Milwaukee production plant some solid/consistent sales orders it'll be profitable.